| Date | Title | Description | Source |
| 12.03.2024 | Clearside Biomedical Announces Fourth Quarter and Full Year ... | - Phase 2b ODYSSEY Wet AMD Trial Remains on Track with Topline Data Expected in Q3 2024 -
- Partner ... | einpresswi... |
| 03.05.2023 | WCVB Channel 5 Chronicle Reporter and Producer Nicole Estaph... | BOSTON (PRWEB) May 03, 2023
The Melanoma Research Foundation (MRF) is thrilled to announce that WCVB... | prweb.com/... |
| 22.11.2022 | Aura, the frame and photo startup, raises $26M as it nears 3... | Aura, a startup founded by early Twitter employees that makes digital frames and photo sharing apps ... | techcrunch... |
| 07.11.2022 | Prevent Blindness Names Jim McGrann Chair of its Board of Di... | Jim McGrann, CEO of Professional Eyecare Associates of America (PECAA), named Chair of the Prevent B... | prweb.com/... |
| 03.11.2021 | Ysios Capital’s portfolio company Aura Biosciences prices IP... | 03/11/2021
Press release
YSIOS CAPITAL’S PORTFOLIO COMPANY AURA BIOSCIENCES PRICES IPO ON NASDAQ.
... | webcapital... |
| 03.11.2021 | Ysios Capital anuncia la salida a bolsa en el NASDAQ de su c... | 03/11/2021
Nota de prensa
YSIOS CAPITAL ANUNCIA LA SALIDA A BOLSA EN EL NASDAQ DE SU COMPAÑÍA PART... | webcapital... |
| 23.03.2021 | Aura Biosciences picks up $80M | Aura Biosciences has raised $80 million in a round co-led by Matrix Capital Management and Surveyor ... | pitchbook.... |
| 22.03.2021 | Aura Biosciences Announces Oversubscribed $80 Million Financ... | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 22, 2021--
Aura Biosciences, a clinical-stage oncology compan... | oaoa.com/n... |
| 22.03.2021 | Aura Biosciences cierra una ronda de $80M liderada por Matri... | 22/03/2021
Nota de prensa
YSIOS CAPITAL PARTICIPA EN LA RONDA DE FINANCIACIÓN DE $80 MILLONES DE S... | webcapital... |
| 22.03.2021 | Aura Biosciences announces oversubscribed $80 million financ... | 22/03/2021
Press release
AURA BIOSCIENCES ANNOUNCES OVERSUBSCRIBED $80M FINANCING.
Proceeds to Su... | webcapital... |
| 22.03.2021 | Aura Biosciences Scores $80M in Financing |
CAMBRIDGE, MA, Aura Biosciences announced the closing of an oversubscribed $80 million financing l... | vcnewsdail... |
| 03.04.2019 | Aura Biosciences nabs $40M Series D | Aura Biosciences, a developer of medicines for the treatment of eye cancer, has raised $40 million i... | pitchbook.... |
| 02.04.2019 | Aura Biosciences cierra una ronda Serie D de $40M liderada p... | 02/04/2019
Nota de prensa
AURA BIOSCIENCES CIERRA UNA RONDA SERIE D DE $40 MILLONES LIDERADA POR M... | webcapital... |
| 02.04.2019 | Aura Biosciences Inks $40M Series D |
CAMBRIDGE, MA, Aura Biosciences today announced that it closed a $40 million Series D financing.
... | vcnewsdail... |
| 02.04.2019 | Aura Biosciences Completes $40M Series D Financing | Aura Biosciences, a Cambridge, Mass.-based leader in the development of novel targeted therapies in ... | finsmes.co... |
| 02.04.2019 | Daily funding roundup - April 2nd, 2019 | DynamiCare raised $4.1M; OnScale raised $10M; Fifth Eye Enables landed $11.5M; Perch secured $220M
D... | vator.tv/n... |
| 21.12.2017 | Arix Bioscience co-leads $30 million financing for Aura Bios... | - | arixbiosci... |
| 21.12.2017 | Aura Biosciences Nabs $30M Series C |
CAMBRIDGE, MA, Aura Biosciences announced today that it closed a $30 million Series C financing.
... | vcnewsdail... |
| 21.12.2017 | Aura Biosciences Raises $30M Series C | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aura Biosciences, a biotechnology company developing a new class ... | citybizlis... |
| 21.12.2017 | Aura Biosciences Completes $30M Series C Financing | Aura Biosciences, a Cambridge, MA-based biotechnology company developing a new class of therapies to... | finsmes.co... |
| 30.09.2016 | Aura Biosciences, participada por Ysios Capital, cierra una ... | 30/09/2016
AURA BIOSCIENCIES, PARTICIPADA POR YSIOS CAPITAL, CIERRA UNA RONDA DE $8 MILLONES.
Aura... | webcapital... |
| 29.09.2016 | Aura Biosciences Secures $8M in Funding | Aura Biosciences, a Cambridge, Mass.-based biotechnology company, secured $8m in funding.
Backers in... | finsmes.co... |
| 29.09.2016 | Aura Biosciences Secures $8 Million in Additional Funding | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aura Biosciences, a biotechnology company developing a new class ... | citybizlis... |
| 29.09.2016 | Aura Biosciences Receives $8M |
CAMBRIDGE, MA, Aura Biosciences announced today that it secured an additional $8 million round of ... | vcnewsdail... |
| 06.03.2015 | Ysios Capital invierte en una ronda de $21 millones cerrada ... | 06/03/2015
YSIOS CAPITAL INVIERTE EN UNA RONDA DE $21 MILLONES CERRADA POR AURA BIOSCIENCES.
La ge... | webcapital... |
| 05.03.2015 | Aura Biosciences pulls in $21M for tumor-targeted rare eye c... | “Our investors share our vision and our conviction that our technology will uniquely enable the deve... | medcitynew... |
| 05.03.2015 | Aura Biosciences Secures $21M Series B Funding | Aura Biosciences, a Cambridge, Mass.-based biotech company developing therapies for rare cancers, se... | finsmes.co... |
| 05.03.2015 | Aura Biosciences Closes $21M Series B |
CAMBRIDGE, MA, Biotech company developing highly tumor-targeted breakthrough therapies for rare ca... | vcnewsdail... |
| 15.08.2014 | Aura Biosciences nabs $4 million for its pseudovirion-based ... | Aura has slowly and steadily been raising capital since its 2009 launch, with a notable 2012 raise o... | medcitynew... |
| 28.12.2012 | Nanotrepreneur-led startup using “pseudovirus” to fight tumo... | It was developed in partnership with the National Cancer Institute. Since the Boston-based biotech w... | medcitynew... |
| 28.08.2011 | Aura Biosciences Raises $2.95M Second Round |
Filings indicate there were 23 investors in the round.
>> Click here for more funding data ... | vcnewsdail... |
| - | Aura Biosciences nabs $4 million for its pseudovirion-based ... | A hot segment of targeted cancer therapy is using synthetic viruses, or pseudovirions, to serve as m... | medcitynew... |
| - | Nanotrepreneur-led startup using “pseudovirus” to fight tumo... | A nanotechnology startup led by Elisabet de los Pinos dubbed a “Nanotrepreneur” by Time Magazine has... | medcitynew... |
| - | Aura Biosciences pulls in $21M for tumor-targeted rare eye c... | Biotech company Aura Biosciences has secured a $21 million Series B round of funding led by financin... | medcitynew... |
